GOECP/SEOR clinical recommendations for lung cancer radiotherapy during the COVID-19 pandemic

Mostra el registre complet Registre parcial de l'ítem

• dc.contributor.author Couñago, Felipe
• dc.contributor.author Navarro-Martin, Arturo
• dc.contributor.author Luna, Javier
• dc.contributor.author Rodríguez de Dios, Núria
• dc.contributor.author Rodríguez, Aurora
• dc.contributor.author Casas, Francesc
• dc.contributor.author García, Rafael
• dc.contributor.author Gómez-Caamaño, Antonio
• dc.contributor.author Contreras, Jorge
• dc.contributor.author Serrano, Javier
• dc.date.accessioned 2022-02-28T07:30:00Z
• dc.date.available 2022-02-28T07:30:00Z
• dc.date.issued 2020
• dc.description.abstract The coronavirus disease 2019 crisis has had a major and highly complex impact on the clinical practice of radiation oncology worldwide. Spain is one of the countries hardest hit by the virus, with devastating consequences. There is an urgent need to share experiences and offer guidance on decision-making with regard to the indications and standards for radiation therapy in the treatment of lung cancer. In the present article, the Oncological Group for the Study of Lung Cancer of the Spanish Society of Radiation Oncology reviews the literature and establishes a series of consensus-based recommendations for the treatment of patients with lung cancer in different clinical scenarios during the present pandemic.
• dc.format.mimetype application/pdf
• dc.identifier.citation Couñago F, Navarro-Martin A, Luna J, Rodríguez de Dios N, Rodríguez A, Casas F, et al. GOECP/SEOR clinical recommendations for lung cancer radiotherapy during the COVID-19 pandemic. World J Clin Oncol. 2020 Aug 24; 11(8): 510-27. DOI: 10.5306/wjco.v11.i8.510
• dc.identifier.doi http://dx.doi.org/10.5306/wjco.v11.i8.510
• dc.identifier.issn 2218-4333
• dc.identifier.uri http://hdl.handle.net/10230/52585
• dc.language.iso eng
• dc.publisher Baishideng Publishing Group
• dc.rights Copyright ©The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: htt p://creativecommons.org/licenses /by-nc/4.0/
• dc.rights.accessRights info:eu-repo/semantics/openAccess
• dc.rights.uri http://creativecommons.org/licenses /by-nc/4.0/
• dc.subject.keyword COVID-19
• dc.subject.keyword Lung cancer
• dc.subject.keyword Pandemic
• dc.subject.keyword Radiotherapy
• dc.subject.keyword Recommendations
• dc.title GOECP/SEOR clinical recommendations for lung cancer radiotherapy during the COVID-19 pandemic
• dc.type info:eu-repo/semantics/article
• dc.type.version info:eu-repo/semantics/publishedVersion